CUV 0.66% $15.10 clinuvel pharmaceuticals limited

Ann: Syd Capital Markets Briefing Presentation, page-9

  1. 92 Posts.
    lightbulb Created with Sketch. 35
    I wonder if those that invested in this company 5 years earlier than where your slide begins , like looking at it?

    All those lacklustre, frustrating, confusing and concerning years laid bare in one small slide.

    I wonder if any institutional investors will be inspired to buy in after seeing it?
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.